Neuroendocrine tumors: Difference between revisions
Jump to navigation
Jump to search
| Line 42: | Line 42: | ||
==External links== | ==External links== | ||
* http://www.cancer.gov/cancertopics/pdq/treatment/isletcell | * [http://www.cancer.gov/cancertopics/pdq/treatment/isletcell National Cancer Institute - General information about Pancreatic Neuroendocrine Tumors] | ||
== Acknowledgements == | == Acknowledgements == | ||
Revision as of 15:29, 10 September 2012
| Neuroendocrine tumors | |
| ICD-9 | 209 |
|---|---|
| ICD-O: | M8013/3, M8041/3, M8246/3, M8247/3, M8574/3 |
| MeSH | D018358 |
|
Neuroendocrine tumors Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Neuroendocrine tumors from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Endoscopy | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
External links
Acknowledgements
The content on this page was first contributed by: C. Michael Gibson, M.S., M.D.